Topische Aknetherapie

  • Harald P. M. Gollnick
Conference paper
Part of the Fortschritte der praktischen Dermatologie und Venerologie book series (DERMATOLOGIE, volume 18)

Zusammenfassung

Während der letzten zehn Jahre ist eine Reihe topischer und systemischer neuer Aknemittel oder Aknemittel in neuen galenischen Formulierungen auf den Markt gekommen. Die Wirkungen bekannter und vor allem neuer topischer Aknemittel sind hinsichtlich ihrer molekularen Wirkungsmechanismen unter Einwirkung auf die wesentlichen vier pathogenetischen Faktoren der Akne besser beleuchtet worden. Obwohl eine enorme Flut an Informationen über klinische Studien vorhanden ist, genügen nicht alle diese Untersuchungen den nunmehr an sie gelegten Ansprüchen der Evidenz-basierten Medizin. In der Zwischenzeit sind in verschiedenen Ländern wie in den Vereinigten Staaten, Frankreich, England, Kanada und Deutschland Leitlinien für die Aknetherapie veröffentlich worden. Da die Fortschritte der Entwicklung in der Therapie und auch die Entdeckungen neuer pathophysiologischer Zusammenhänge kontinuierlich publiziert werden, bedarf es auch der Adaption der therapeutischen Vorgehensweise [6,11,25].

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Bershard S, Singer GK, Parente JE et al. (2002) Successful treatment of acne vulgaris using a new method. Results of a randomized vehicle controlled trial of short-contact therapy with 0,1 % tazarotene gel. Arch Dermatol 138: 481 -489Google Scholar
  2. 2.
    Bojar RA, Cunliffe WJ, Holland KT (1995)The short-therm treatment of acne vulgaris with benzoyl peroxide: effects on the surface and follicular cutaneous microflora. Br J Dermatol 132: 204–298PubMedCrossRefGoogle Scholar
  3. 3.
    Caron D, Sorba V, Kerrouche N, Clucas A (1997) Split-face comparison of adapalene 0,1% gel and tretinoin 0,025% gel in acne patients. J Am Acad Dermatol 36: 110– 112CrossRefGoogle Scholar
  4. 4.
    Cunliffe WJ, Caputo R, Dreno B, Forstrom L, Heenen M, Orfanos CE, Privat Y (1997) Clinical efficacy and safety comparison of adapalene gel and tretinoin gel in the treatment of acne vulgaris. J Am Acad Dermatol 36: 126–134CrossRefGoogle Scholar
  5. 5.
    Robledo Aguilar A, Meynadier J, Alirezai M et al. (1997) Clinical efficacy and safety comparison of adapalene gel and tretinoin gel in the treatment of acne vulgaris: Europe and US multicenter trials. J Am Acad Dermatol 36: 126– 134CrossRefGoogle Scholar
  6. 6.
    Cunliffe WJ, Goulden V (2000) Phototherapy and acne vulgaris. Br J Dermatol 142: 855–856PubMedCrossRefGoogle Scholar
  7. 7.
    Cunliffe WJ, Gollnick H (2001) Acne: diagnosis and management. Dunitz, LondonGoogle Scholar
  8. 8.
    Eady EA (1998) Bacterial resistence in acne. Dermatology 196:59–66PubMedCrossRefGoogle Scholar
  9. 9.
    Foster RH, Brogden RN, Benfield P (1998) Tazarotene. Drugs 55: 705–711PubMedCrossRefGoogle Scholar
  10. 10.
    Glass D, Boorman GC, Stables GI, Cunliffe WJ, Goode K (1999) A placebo-controlled clinical trial to compare a gel containing a combination of isotretinoin (0,05%) and erythromycin (2%) with gels containing isotretinoin (0,05 %) or erythromycin (2%) alone in the topical treatment of acne vulgaris. Dermatology 199: 242–247PubMedCrossRefGoogle Scholar
  11. 11.
    Gloor M, Pfahler E, Neumann W, Hoffler U et al. (1982) Topische Behandlung der Acne vulgaris mit Erythromycin und Benzoylperoxid. Z Hautkr 57: 867–878PubMedGoogle Scholar
  12. 12.
    Gollnick H, Schramm M (1998) Topical therapy in acne. J Eur Acad Dermatol Venerol 11 [suppl 1]: 8– 12, discussion 28–29CrossRefGoogle Scholar
  13. 13.
    Goswami BC, Baishya B, Barua AB, Olson JA (1999) Topical retinoyl betaglucuronide is an effective treatment of mild to moderate ance vulgaris in Asian-Indian patients. Skin Pharmacol Appl Skin Physiol 12: 167– 173PubMedCrossRefGoogle Scholar
  14. 14.
    Graupe K, Cunliffe W, Gollnick H, Zaumseil R (1996) Efficacy and safety of topical azelaic acid (20% cream): an overview of results from European clinical trials and experimental reports. Cutis 57 [suppl 1]: 13–19Google Scholar
  15. 15.
    Hensby C, Cavey D, Bouclier M et al. (1990) The in vivo and in vitro antiinflammatory activity of CD271: a new reti-noid-like-modulator of cell differentiation. Agents Action 29:56–58CrossRefGoogle Scholar
  16. 16.
    Hughes D, Norris J, Cunliffe W (1992) A double-blind evalution of topical isotretinoin 0,05 %, benzoyl peroxide gel 5 % a nd placebo in patients with acne. Clin Exp Dermatol 17:165–168PubMedCrossRefGoogle Scholar
  17. 17.
    Kakita L (2000) Tazarotene versus tretinoin or adapalene in the treatment of acne vulgaris. J Am Acad Dermatol 43: 41 - 44CrossRefGoogle Scholar
  18. 18.
    Kligman AM, Mills OH, McGinley KJ, Leyden JJ (1975) Acne therapy with tretinoin in combination with antibiotics. Acta Dermatovenereol (Stockh) 74 [suppl]: 111–115Google Scholar
  19. 19.
    Korting HC, Braun-Falco O (1989) Efficacy and tolerability of combined topical treatment of acne vulgaris with tretinoin and erythromycin in general practice. Drugs Exp Clin Res 15: 447–451PubMedGoogle Scholar
  20. 20.
    Lookingbill DP, Chalker DK, Lindholm JS et al. (1997) Treatment of acne with a combination clindamycin/BPO gel compared with clindamycin gel, BPO gel and vehicle gel. J Am Acad Dermatol 37: 590–595PubMedCrossRefGoogle Scholar
  21. 21.
    Swinehart JM, Schelling DJ, Klauda HC. (1997) Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations. J Am Acad Dermatol 37: 590–595PubMedCrossRefGoogle Scholar
  22. 22.
    Lucky AW, Cullen SI, Funiceila T et al. (1998) Doubleblind, vehicle-controlled multicenter comparison of two 0,025 % tretinoin creams in patiens with acne vulgaris. J Am Acad Dermatol 38: 24–30CrossRefGoogle Scholar
  23. 23.
    Mills OH jr, Kligman AM (1978) Treatment of acne vulgaris with topically applied erythromycin and tretinoin. Acta Dermatovenereol (Stockh) 58: 555–557Google Scholar
  24. 24.
    Milikan LE (2000) Adapalene: an update on newer comparative studies between the various retinoids. Int J Dermatol 39:784–788CrossRefGoogle Scholar
  25. 25.
    Morel P, Vienne MP, Beylot C et al. (1999) Clinical efficacy and safety of a topical combination of retinaldehyde 0,1 % with erythromycin 4% in acne vulgaris. Clin Exp Dermatol 24: 354–357PubMedCrossRefGoogle Scholar
  26. 26.
    Papageorgiou P, Katsambas A, Chu A (2000) Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris. Br J Dermatol 142: 973–978PubMedCrossRefGoogle Scholar
  27. 27.
    Plewig G, Kligman AM (2000) Acne and rosacea, 3rd ed. Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar
  28. 28.
    Shalita AR, Harris H (1972) Comedo extraction. Arch Dermatol 105: 759–760PubMedCrossRefGoogle Scholar
  29. 29.
    Thomson KF, Goulden V, Sheehan-Dare R, Cunliffe WJ (1999) Light cautery of macrocomedones under general anesthesia. Br J Dermatol 141: 595–596PubMedCrossRefGoogle Scholar
  30. 30.
    Thielitz A, Helmdach M, Röpke EM, Gollnick H (2001) Lipid analysis of follicular casts from cyanoacrylate strips as a new method for studing therapeutic effects of antiacne agents. Br J Dermatol 145: 19–27PubMedCrossRefGoogle Scholar
  31. 31.
    Zouboulis CC, Derumeaux L, Decroix J et al. (2000) A multicentre, single-blind, randomized comparison of a fixed clindamycin phosphate/tretinoin gel formulation (velac) applied once daily and a clindamycin lotion formulation (dalacin T) applied twice daily in the topical treatment of acne vulgaris. Br J Dermatol 143: 498–505PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • Harald P. M. Gollnick

There are no affiliations available

Personalised recommendations